159 related articles for article (PubMed ID: 30884341)
1. Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer.
Aarts AMWM; Duffy SW; Geurts SME; Vulkan DP; Houssami N; Zappa M; Nagtegaal ID; Verbeek ALM; Broeders MJM
Breast; 2019 Jun; 45():70-74. PubMed ID: 30884341
[TBL] [Abstract][Full Text] [Related]
2. Quantifying the duration of the preclinical detectable phase in cancer screening: a systematic review.
Geurts SME; Aarts AMWM; Verbeek ALM; Chen THH; Broeders MJM; Duffy SW
Epidemiol Health; 2022; 44():e2022008. PubMed ID: 34990529
[TBL] [Abstract][Full Text] [Related]
3. Is clinical breast examination effective in Japan? Consideration from the age-specific performance of breast cancer screening combining mammography with clinical breast examination.
Ohta K; Kasahara Y; Tanaka F; Maeda H
Breast Cancer; 2016 Mar; 23(2):183-9. PubMed ID: 24925524
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer detection among Irish BRCA1 & BRCA2 mutation carriers: a population-based study.
Walsh EM; Farrell MP; Nolan C; Gallagher F; Clarke R; McCaffrey JA; Kennedy MJ; Barry M; Kell MR; Gallagher DJ
Ir J Med Sci; 2016 Feb; 185(1):189-94. PubMed ID: 25673166
[TBL] [Abstract][Full Text] [Related]
5. The contribution of clinical breast examination to the accuracy of breast screening.
Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
[TBL] [Abstract][Full Text] [Related]
6. Early detection of second breast cancers improves prognosis in breast cancer survivors.
Houssami N; Ciatto S; Martinelli F; Bonardi R; Duffy SW
Ann Oncol; 2009 Sep; 20(9):1505-1510. PubMed ID: 19297316
[TBL] [Abstract][Full Text] [Related]
7. The incremental contribution of clinical breast examination to invasive cancer detection in a mammography screening program.
Oestreicher N; Lehman CD; Seger DJ; Buist DS; White E
AJR Am J Roentgenol; 2005 Feb; 184(2):428-32. PubMed ID: 15671358
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
Warner E; Plewes DB; Hill KA; Causer PA; Zubovits JT; Jong RA; Cutrara MR; DeBoer G; Yaffe MJ; Messner SJ; Meschino WS; Piron CA; Narod SA
JAMA; 2004 Sep; 292(11):1317-25. PubMed ID: 15367553
[TBL] [Abstract][Full Text] [Related]
9. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.
Houssami N; Bernardi D; Caumo F; Brunelli S; Fantò C; Valentini M; Romanucci G; Gentilini MA; Zorzi M; Macaskill P
Breast; 2018 Apr; 38():150-153. PubMed ID: 29328943
[TBL] [Abstract][Full Text] [Related]
10. Predictors of surveillance mammography outcomes in women with a personal history of breast cancer.
Lowry KP; Braunstein LZ; Economopoulos KP; Salama L; Lehman CD; Gazelle GS; Halpern EF; Giess CS; Taghian AG; Lee JM
Breast Cancer Res Treat; 2018 Aug; 171(1):209-215. PubMed ID: 29748762
[TBL] [Abstract][Full Text] [Related]
11. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
[TBL] [Abstract][Full Text] [Related]
12. Short report: Limited effectiveness of screening mammography in addition to clinical breast examination by trained nurse midwives in rural Jakarta, Indonesia.
Kardinah D; Anderson BO; Duggan C; Ali IA; Thomas DB
Int J Cancer; 2014 Mar; 134(5):1250-5. PubMed ID: 24037942
[TBL] [Abstract][Full Text] [Related]
13. Incidence and tumour characteristics of bilateral and unilateral interval breast cancers at screening mammography.
van Bommel RMG; Voogd AC; Nederend J; Setz-Pels W; Louwman MWJ; Strobbe LJ; Venderink D; Tjan-Heijnen VCG; Duijm LEM
Breast; 2018 Apr; 38():101-106. PubMed ID: 29306176
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer survivors' risk of interval cancers and false positive results in organized mammography screening.
Njor SH; Vejborg I; Larsen MB
Cancer Med; 2020 Aug; 9(16):6042-6050. PubMed ID: 32608178
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of mammography and clinical breast examination in the implementation of breast cancer screening programs in Colombia.
Alba LH; Díaz S; Gamboa O; Poveda C; Henao A; Perry F; Duggan C; Gil F; Murillo R
Prev Med; 2018 Oct; 115():19-25. PubMed ID: 30092313
[TBL] [Abstract][Full Text] [Related]
16. The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How?
Barton MB; Harris R; Fletcher SW
JAMA; 1999 Oct; 282(13):1270-80. PubMed ID: 10517431
[TBL] [Abstract][Full Text] [Related]
17. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
[TBL] [Abstract][Full Text] [Related]
18. Mammography benefit in the Canadian National Breast Screening Study-2: a model evaluation.
Rijnsburger AJ; van Oortmarssen GJ; Boer R; Draisma G; To T; Miller AB; de Koning HJ
Int J Cancer; 2004 Jul; 110(5):756-62. PubMed ID: 15146566
[TBL] [Abstract][Full Text] [Related]
19. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
20. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
